Roxithromycin,,Active Pharmaceutical Ingredients,Other Active Pharmaceutical Ingredients
Is Manufacturer
No
Product Description
COS/CEP, US FDA to be submitted in 2013.
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Roxithromycin is a semi-synthetic <strong>macrolide antibiotic</strong> derived from erythromycin, produced via chemical modification to enhance stability and bioavailability. Its molecular formula is <strong>C21H35NO7</strong> with CAS No. <strong>80201-81-0</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Human Medicine:</strong> Treatment of respiratory tract infections including bronchitis and pneumonia.</li>
<li><strong>Veterinary Sector:</strong> Management of livestock bacterial infections in cattle and poultry.</li>
<li><strong>Pharmaceutical Manufacturing:</strong> Bulk API supply for generic tablet and suspension formulations.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in patients with hypersensitivity to macrolides; requires storage below 25°C in dry conditions to prevent degradation. Strict adherence to dosage protocols is essential to mitigate hepatic risks.</p>